康恩贝上半年中药业务利润大增143.01%

During the reporting period, the company's traditional Chinese medicine health business achieved stable growth, with an increase in its proportion of total revenue. In the first half of the year, the company's traditional Chinese medicine health business achieved a revenue of 2.518 billion yuan, a year-on-year increase of 32.22%, accounting for 66.88% of the company's total revenue, an increase in proportion. All business segments experienced varying degrees of revenue growth compared to the same period last year, further optimizing the business structure. The self-care product business achieved a revenue of 1.777 billion yuan, a year-on-year increase of 35.64%, accounting for 47.2% of the company's revenue, an increase of approximately 5 percentage points compared to the same period last year. Among them, the over-the-counter medicine business achieved a revenue of 1.487 billion yuan, a year-on-year increase of 39.06%; and the health consumer product business achieved a revenue of 290 million yuan, a year-on-year increase of 20.45%.